Ethical dimensions of nuchal translucency screening.
First-trimester screening for NT, when conducted according to accepted standards of quality, is a reliable diagnostic screen. There is no compelling beneficence-based argument opposed to offering it, and offering it is an important autonomy-enhancing strategy. Screening should be offered only in centers where high quality is available. In our view, the results of ongoing trials will enhance this position.
Chasen
Stephen T
ST
Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, 525 East 68th Street, Room J130, New York, NY, USA. stchasen@med.cornell.edu
Skupski
Daniel W
DW
D004314:Down Syndrome / Q000000981:diagnostic imaging*; D005260:Female; D005315:Fetal Diseases / Q000000981:diagnostic imaging; D006801:Humans; D009333:Neck / Q000000981:diagnostic imaging*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012307:Risk Factors; D016216:Ultrasonography, Prenatal